Bij off-label gebruik voor gewichtsverlies is vergoeding meestal niet mogelijk
It showed about 15% weight loss in trials, with very promising results for reducing liver fat in people with fatty liver disease
For more insight into how our research team vets, qualifies, and ranks providers, review our full methodology here
Liability in these cases may depend on several factors, including which pharmacy or outsourcing facility produced the compounded medication, what formulation was used, whether the product contained the same active ingredient, and what warnings or instructions were provided to the patient
Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like tirzepatide and semaglutide but has increased efficacy
Western vendors who source from Chinese manufacturers (which many do) essentially perform the vetting process on your behalf and charge a markup for that service